PATENT CLAIM ANALYSIS

Application Number: 16053412
Application Type: Utility
Filing Date: 2018-08
Publication Date: 2018-11
Patent Classification: ["514", "183000"]

Abstract:
Described are a group of isoxazol-3(2H)-one analogues and their use in topical formulations for the treatment and prophylaxis of dermatological disorders.

Claim (Index 14):
The method according to  claim 12  characterized in that the dermatologically acceptable carrier is composed of vaselinum album, paraffinum liquidum, cetostrearyl alcohol, cetomacrogol 1000, chlorocresol or bensylalcohol, sodium dihydrogen phosphate dehydrate, concentrated phosphoric acid (85%) and distilled water.

Metadata:
- Claim Count in Document: 3.0
- Percentile: 96.0
- Lexical Diversity: 1.08333
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['12755010', '14778046', '11737069', '11595187', '14345982']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7854409229435266
- 35 USC 102 Novelty (BERT): 0.5001229785510891
- Combined Prediction Score: 0.7569091285042828
- Mean Citation Score: 218.8076
- Max Citation Score: 229.31332
- Similarity Product: 155.76580222346786

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test